Skip to main content
< Back
About
About the conference
Latest updates
Organisers & Partners
App
Press room
Programme 19
Full programme
Tracks
Speakers 19
Keynote speakers
All speakers
Side events 19
Venue 19
About the venue
Location
Rooms
Subscribe
Overdose
Sessions
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
New psychoactive substances
Health consequences
Overdose — Treatment: medical/pharmacological
10:50
Understanding and improving health and social outcomes
10:50
to
12:20
Networking zone 3 (N3)
Sanna Rönkä
Opioid-related deaths in Europe and Australia
10:50
to
12:20
Main stage
Eilish Gilvarry
Understanding behaviours, risks and harms
10:50
to
12:20
Networking zone 3 (N3)
Xavier Majó
13:20
Insights on opioid substitution treatment, prison post-release mortality, and cross indicator analysis
Improving the validity of drug-related deaths data for policy making
13:20
to
14:50
Central square 1 (C1)
Isabelle Giraudon
Cannabis — risks and responses
13:20
to
14:50
Networking zone 4 (N4)
Jennifer Price
Evidence to guide future practice and policy
Enhancing hepatitis C treatment outcomes among people who use drugs
13:20
to
14:50
Insights zone 1 (I1)
Catharina Matheï
Adrian Dunlop
Reducing drug-related deaths
13:20
to
14:50
Central square 2 (C2)
Catherine Comiskey
The Reitox network poster session
13:20
to
14:50
Guided poster tours room
Nadine Berndt
15:00
Improving responses to opioid-related harm
15:00
to
16:30
Central square 3 (C3)
Steve Gust
Take-home naloxone — its role in preventing opioid-related deaths in Europe
15:00
to
16:30
Insights zone 3 (I3)
Dagmar Hedrich
Sir John Strang
Opioid-related deaths and other harms: current and emerging lessons - SSA poster session
15:00
to
16:30
Guided poster tours room
Sarah Welch
18:30
Opioids — current and emerging lessons
18:30
to
19:30
Networking zone 4 (N4)
Roumen Sedefov
10:45
Opioid-related deaths: learning from epidemiological studies
10:45
to
12:15
Insights zone 3 (I3)
Sarah Welch
Presentations
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Wednesday, 23 October
11:00
Short communication
Portuguese gender-sensitive harm reduction services: bridging the gap
11:00
to
11:10
Networking zone 3 (N3)
Oral presentation
Drug deaths in Scotland: inevitable or preventable?
11:00
to
11:15
Main stage
Roy Robertson
11:10
Short communication
A change in the prescribing practice of prebagalin that has had a direct negative effect on drug-induced deaths in Ireland
11:10
to
11:20
Networking zone 3 (N3)
Ena Lynn
11:15
Oral presentation
Cause-specific excess mortality in people who use opioids illicitly: systematic review and meta-analysis
11:15
to
11:30
Main stage
Sarah Larney
11:30
Short communication
Performance enhancing drugs. Results from a Belgian survey on PED use among workers
11:30
to
11:40
Networking zone 3 (N3)
Marie-Claire Lambrechts
Oral presentation
Prevention of drug related mortality: the role of opioid agonist treatment
11:30
to
12:00
Main stage
Matthew Hickman
Louisa Degenhardt
11:40
Short communication
Drug and alcohol treatment: how much does it cost in Europe?
11:40
to
11:50
Networking zone 3 (N3)
Claudia Costa Storti
11:50
Short communication
Young people's exposure to gambling advertisements: a mixed methods study in Australia.
11:50
to
12:00
Networking zone 3 (N3)
Hannah Pitt
12:00
Short communication
Street Work Nursing as an innovative strategy in the care for dually diagnosed individuals: reflections on a pilot study
12:00
to
12:10
Networking zone 3 (N3)
Ilse Goethals
Oral presentation
Discussant
12:00
to
12:20
Main stage
Edward Nunes
12:10
Short communication
Dissuasion, the effectiveness of the intervention and good practices
12:10
to
12:20
Networking zone 3 (N3)
Américo Gegaloto
13:20
Oral presentation
Epidemiology of drug-related deaths in Europe, and focus in two countries on underestimation and possible corrections of the reported number of deaths
13:20
to
14:50
Central square 1 (C1)
Isabelle Giraudon
Oral presentation
Comparison between drug-related deaths data from special and general mortality registers in Austria. Implications for monitoring and policy making
13:20
to
14:50
Central square 1 (C1)
Judith Anzenberger
Oral presentation
Mortality during and after opioid substitution treatment in Austria 2002 to 2016
13:20
to
14:50
Central square 1 (C1)
Martin Busch
Oral presentation
Prison post-release mortality among drug-users in Lithuania
13:20
to
14:50
Central square 1 (C1)
Lina Jurgelaitiene
15:10
Oral presentation
The evolving opioid overdose crisis and the rising role of methamphetamine
15:10
to
15:25
Central square 3 (C3)
Christopher Jones
15:25
Oral presentation
Examination of emerging adults with opioid use disorders
15:25
to
15:40
Central square 3 (C3)
Holly Hills
15:40
Oral presentation
Recent non-fatal opioid overdose: the effects of health service utilisation, alcohol and other drug use and demographic factors
15:40
to
15:55
Central square 3 (C3)
Penelope Hill
15:55
Oral presentation
In utero opioid exposure and risk of infections in childhood: a multinational Nordic cohort study
15:55
to
16:10
Central square 3 (C3)
Marte Handal
16:10
Oral presentation
Reducing inappropriate use of prescription opioids in hospital patients
16:10
to
16:25
Central square 3 (C3)
Erin Winstanley
Thursday, 24 October
11:00
Short communication
Neuropsychological functioning, psychopathology, and parenting behaviours in the context of substance use disorders: which are the implications for treatment?
11:00
to
11:10
Networking zone 3 (N3)
Alessio Porreca
11:10
Short communication
Childhood adversity within adolescent friendship groups: Implications for subsequent substance use disorders
11:10
to
11:20
Networking zone 3 (N3)
Lauren Bishop
11:20
Short communication
Cause-specific hospitalisation and death in a cohort of people who use heroin and crack cocaine in London, England: the importance of non-communicable diseases, skin infections, head injuries and dental caries
11:20
to
11:40
Networking zone 3 (N3)
Dan Lewer
11:30
Short communication
Yearning to be better than good –Lithuanian students of medicine use of cognitive enhancers among
11:30
to
11:40
Networking zone 3 (N3)
Aiste Lengvenyte
11:40
Short communication
New issues regarding drug-related deaths: combined suicide
11:40
to
11:50
Networking zone 3 (N3)
Mateja Jandl
11:50